Alkermes plc
ALKS
$27.00
$0.411.54%
Weiss Ratings | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | B | |||
Rating Factors | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.76 | |||
Price History | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -17.30% | |||
30-Day Total Return | -21.35% | |||
60-Day Total Return | -7.06% | |||
90-Day Total Return | -6.96% | |||
Year to Date Total Return | -6.09% | |||
1-Year Total Return | 8.04% | |||
2-Year Total Return | -4.86% | |||
3-Year Total Return | -4.36% | |||
5-Year Total Return | 78.41% | |||
52-Week High % Change | -27.05% | |||
52-Week Low % Change | 16.11% | |||
Price | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $36.45 | |||
52-Week Low Price | $22.90 | |||
52-Week Low Price (Date) | Jul 10, 2024 | |||
52-Week High Price (Date) | Feb 18, 2025 | |||
Valuation | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 4.32B | |||
Enterprise Value | 3.65B | |||
Price/Earnings (TTM) | 12.16 | |||
Earnings Per Share (TTM) | 2.19 | |||
Earnings Per Share Growth | 5.71% | |||
Price/Earnings To Growth | 2.13 | |||
Price/Sales (TTM) | 2.84 | |||
Price/Book (Q) | 2.94 | |||
Enterprise Value/Revenue (TTM) | 2.34 | |||
Price | $27.00 | |||
Enterprise Value/EBITDA (TTM) | 8.12 | |||
Enterprise Value/EBIT | 8.67 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 166.55M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 353 1 772 8000 | |||
Address | -- | |||
Website | www.alkermes.com | |||
Country | Ireland | |||
Year Founded | 1987 | |||
Profitability | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 27.00% | |||
Profit Margin | 23.56% | |||
Management Effectiveness | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 12.54% | |||
Return on Equity | 27.90% | |||
Income Statement | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.56B | |||
Total Revenue (TTM) | 1.56B | |||
Revenue Per Share | $9.35 | |||
Gross Profit (TTM) | 1.31B | |||
EBITDA (TTM) | 449.17M | |||
EBIT (TTM) | 420.64M | |||
Net Income (TTM) | 367.07M | |||
Net Income Avl. to Common (TTM) | 367.07M | |||
Total Revenue Growth (Q YOY) | 13.91% | |||
Earnings Growth (Q YOY) | -9.23% | |||
EPS Diluted (TTM) | 2.19 | |||
EPS Diluted Growth (Q YOY) | 33.09% | |||
Balance Sheet | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 751.67M | |||
Cash Per Share (Q) | $4.51 | |||
Total Current Assets (Q) | 1.42B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.46B | |||
Current Ratio (Q) | 3.042 | |||
Book Value Per Share (Q) | $9.03 | |||
Total Assets (Q) | 2.06B | |||
Total Current Liabilities (Q) | 465.20M | |||
Total Debt (Q) | 75.54M | |||
Total Liabilities (Q) | 590.59M | |||
Total Common Equity (Q) | 1.46B | |||
Cash Flow | ALKS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -111.31M | |||
Cash from Financing (TTM) | -494.14M | |||
Net Change in Cash (TTM) | -166.32M | |||
Levered Free Cash Flow (TTM) | 336.36M | |||
Cash from Operations (TTM) | 439.12M | |||